STA-5326 Meslylate to Treat Gut Inflammation Associated With Common Variable Immunodeficiency

Common variable immunodeficiency

Joanne Kurtzberg, MD – Common variable immunodeficiency

Role of Antibiotic Therapy or Immunoglobulin On iNfections in hAematoLogy: Immunoglobulin Stopping or Extension Senolytics Treatment of Interstitial Lung Disease in Common Variable Immunodeficiency Composition and Function of Gut Microbiota in Porto-sinusoidal Vascular Disease Associated With Variable Common Immunodeficiency Abatacept for the Treatment of Common Variable Immunodeficiency With Interstitial Lung Disease Human IgGs and Endothelial Function in Vivo in Humans The Rifaximin Study in CVID “Prime Boost” Vaccination Strategy Combining Conjugated Anti- Pneumococcal Vaccine (s0) and Polysaccharide Anti- Pneumococcal Vaccine (s4) Compared to Polysaccharide Anti- Pneumococcal Vaccine Alone (s4) In Patients With Common Variable Immunodeficiency Improving the Diagnosis of Common Variable Immune Deficiency Immune System and Gut Abnormalities in Patients With Common Variable Immunodeficiency With and Without Gastrointestinal Symptoms STA-5326 Meslylate to Treat Gut Inflammation Associated With Common Variable Immunodeficiency